Summit on Cancer Health Disparities (SCHD25)

Seattle, WA US
April 25, 2025 to April 27, 2025

The Summit on Cancer Health Disparities 2025 (SCHD25) is a premier annual event focused on addressing cancer health disparities. The conference serves to bridge research and practice, offering practical strategies to improve cancer care delivery and outcomes. SCHD25 will unite oncology professionals, researchers, policymakers, and other stakeholders looking to address factors contributing to cancer health disparities with evidence-based interventions.

The conference features lectures, panel discussions, debates, and case-based discussions led by leaders in cancer care. Advances in implementation science and artificial intelligence will provide additional insights into how barriers to cancer care can be alleviated. The event includes oral and poster abstract sessions.  

As an accredited CME activity, SCHD25 promotes interdisciplinary interactions and partnerships, equipping participants with tools to translate research into actionable strategies for diverse healthcare settings.

Target Audience

  • Oncologists
  • Nurse Practitioners
  • Physician Assistants
  • Nurses
  • Pharmacists
  • Fellows/Residents
  • Researchers
  • Others interested in cancer disparities

Organizing Committee 

Program Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Co-Chairs:

Ana María López, MD, MPH - Sidney Kimmel Cancer Center, Thomas Jefferson University

David Aboulafia, MD - Virginia Mason Medical Center

Organizing Committee:

Manisha Bhattacharya, MD, MBA - University of Pittsburgh Medical Center

Jorge E. Cortes, MD  -   Georgia Cancer Center at Augusta University

Don S. Dizon, MD - Lifespan Cancer Institute, Rhode Island Hospital and The Warren Alpert Medical School of Brown University

Manish Kohli, MD - Huntsman Cancer Institute, University of Utah

Mark Pegram, MD - Stanford University

Martha Pritchett Mims, MD, PhD - Baylor College of Medicine

Prakash C. Neupane, MBBS - University of Kansas Medical Center

Jerald Radich, MD - Fred Hutchinson Cancer Center and University of Washington

Rayne Helen Rouce, MD - Baylor College of Medicine and Texas Children's

Gregory Vidal, MD, PhD - West Cancer Center

Siddhartha Yadav, MBBS, MD - Mayo Clinic

Abstract Committee Co-Chairs:

Martha Pritchett Mims, MD, PhD - Baylor College of Medicine

Gregory Vidal, MD, PhD - West Cancer Center

Abstract Committee:

Ursa Brown-Glaberman, MD - University of New Mexico Comprehensive Cancer Center

Shipra Gandhi, MD - Roswell Park Comprehensive Cancer Center

Charles Jiang, MD - UT Southwestern Medical Center

Darya Kizub, MD - MD Anderson Cancer Center

Don S. Dizon, MD - Lifespan Cancer Institute, Rhode Island Hospital and The Warren Alpert Medical School of Brown University

Manish Kohli, MD - Huntsman Cancer Institute, University of Utah

Cecilia Yeung, MD - Fred Hutchinson Cancer Center and University of Washington

Media and Publications Committee Co-Chairs

Arya Mariam Roy, MD - The Ohio State University

Matt Lambert - Binaytara Foundation

Abstract Submission

https://abstracts.binayfoundation.org/conference/summit-on-cancer-health-disparities-schd25

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Identify and critically analyze the complex interplay of factors contributing to cancer health disparities across diverse populations.
  • Apply implementation science principles to develop and implement evidence-based interventions to address cancer disparities within their specific contexts.
  • Evaluate the effectiveness of various strategies for improving cancer outcomes among underserved populations, including patient navigation, community engagement, and policy advocacy.
  • Collaborate with interdisciplinary teams to develop and implement comprehensive cancer control plans that address the unique needs of marginalized communities, and advocate for policies and system changes to reduce cancer health disparities and promote health equity.
  • Review the impact of AI on access to cancer care.

Hotel Room Reservation

A limited number of guestrooms are reserved at the Seattle Marriott Waterfront for the participants of this meeting at a discounted rate of $247 per night. The room rate does not include any additional fees or applicable taxes.

CUTOFF - Thursday, March 27, 2025.

Parking 

Hotel offers daily valet parking at $58.

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 17.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 17.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 17.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 17.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 17.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 17.00 Contact Hours.
Course opens: 
07/08/2024
Course expires: 
07/28/2025
Event starts: 
04/25/2025 - 8:00am PDT
Event ends: 
04/27/2025 - 12:00pm PDT
Cost:
$350.00

DAY 1 - APRIL 25, 2025

All times are listed in Pacific Time (PT)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:15 AM  Welcome and Opening Remarks


08:15 AM – 09:15 AM  Session 1: Evolving the Landscape Towards Cancer Health Equity

Session Chairs: David Aboulafia, MD & Jessica Y. Islam, PhD, MPH

08:15 AM – 08:35 AM  Data Gaps and Opportunities for Modeling Cancer Health Equity

08:35 AM – 08:50 AM  Racial/Ethnic Disparities: Discrimination’s Impact on Health-Related Quality of Life-An All of Us Cancer Survivors - Albert J. Farias, PhD, MPH

08:50 AM – 09:05 AM  Conceptual and Empirical Approaches for Cancer Health Disparities Research

09:05 AM – 09:15 AM  Panel Discussion


09:15 AM – 10:15 AM  Session 2: Root Causes of Cancer Disparities: An Intersectional Perspective

Session Chair: Rayne Helen Rouce, MD

09:15 AM – 09:35 AM  Keynote Address

09:35 AM – 10:15 AM  Panel Discussion - Banu Symington, MD


10:15 AM – 10:30 AM  Break & Exhibits


10:30 AM – 12:00 PM  Session 3: Breakout Sessions

10:30 AM - 11:15 AM  Breakout Session A: Smoking Related Cancer Disparities - Lei Deng, MD

11:15 AM - 12:30 AM  Breakout Session B: 


12:00 PM – 01:00 PM  Lunch & Exhibits


01:00 PM 02:00 PM  Session 4: Introduction to Implementation Science: Bridging the Gap Between Research and Practice

Session Chair: Siddhartha Yadav, MBBS, MD & Catherine Duggan, PhD

01:00 PM – 01:20 PM  Keynote Speech - Bradford Felker, MD

01:20 PM – 02:00 PM  Panel Discussion - Salene M. W. Jones, PhD; Katrina Ortblad, ScD, MPH


02:00 PM – 03:00 PM  Session 5: Successful Implementation of Equity-Enhancing Interventions

Session Chair: Martha Pritchett Mims, MD, PhD

02:00 PM – 02:20 PM  Pragmatica Trial - Karen Reckamp, MD

02:20 PM – 02:40 PM  Development and Application of a Financial Toxicity Tool - Hoda Badr, PhD

02:40 PM – 03:00 PM  Addressing Breast Cancer Equity Through Virtual Community Oncology Navigation and Engagement (vCONET) - Manisha Salinas, PhD


03:00 PM – 03:15 PM  Break & Exhibits


03:15 PM – 04:15 PM  Session 6: Overcoming Barriers to Implementation

Session Chairs: Gregory Vidal, MD, PhD & Sonya Reid, MD, MPH

03:15 PM – 03:30 PM  Barriers and Facilitators to Clinical Trial Diversity - Yara Abdou, MD

03:30 PM – 03:45 PM  Implementation of Precision Medicine and its Impact on Access to Care and Health Equity Disparity - Megan Roberts, PhD

03:45 PM – 04:00 PM  Barriers to Implementing Evidence-Based Practices in Diverse Communities

04:00 PM – 04:15 PM  Panel Discussion 


**Open to all non-industry attendees**

06:00 PM – 09:00 PM  Career Connections Event

**This is a non-CME activity**


 

DAY 2 - APRIL 26, 2025

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 09:00 AM  Session 7: Leveraging Technology and AI to Support Cancer Health Equity

Session Chair: Manish Kohli, MD

08:00 AM – 08:20 AM  Keynote Address - Young J. Juhn, MD, MPH, ABCI

08:20 AM – 08:40 AM  Emerging Technology to Support Cancer Health Equity - Hoifung Poon, PhD

08:40 AM – 09:00 AM  Panel Discussion - Helen Storey, PhD


09:00 AM – 10:00 AM  Session 8: Community Outreach and Engagement: What is the Evidence of Impact?

Session Chair: Don S. Dizon, MD, FACP, FASCO

09:00 AM – 09:10 AM  Engagement with Cancer Survivors and Communities at Risk - Memnun Seven, RN, MSN, PhD, FAAN

09:10 AM – 09:20 AM  Effective Utilization of Community Advisory Boards

09:20 AM – 09:30 AM  Engagement in a New Media Environment - Vida Henderson, PhD, PharmD, MPH, MFA

09:30 AM – 10:00 AM  Panel Discussion


10:00 AM – 10:30 AM  Break & Exhibits


10:30 AM – 12:00 PM  Session 9: Breakout Sessions

10:30 AM - 11:15 AM  Breakout Session C:

11:15 AM - 12:00 PM  Breakout Session D:


12:00 PM – 01:00 PM  Lunch & Exhibits


01:00 PM – 02:00 PM  Session 10: Measuring and Evaluating Equity-Enhancing Interventions

Session Chair: Ana María López, MD , MPH, MACP

01:00 PM – 01:30 PM  Keynote Address

01:30 PM – 02:00 PM  Panel Discussion


02:00 PM – 03:00 PM  Session 11: Building Sustainable Partnerships for Cancer Health Equity

Session Chair: Anu Agrawal, MD

02:00 PM – 03:00 PM  Panel Discussion


03:00 PM – 03:15 PM  Break & Exhibits


03:15 PM – 05:00 PM  Session 12: Global Oncology

Session Chair: Prakash C. Neupane, MBBS

03:15 PM – 03:35 PM  Keynote Speech - Sustainable Care Models in Low and Middle Income Countries

03:35 PM – 05:00 PM  Panel Discussion - Steven Kussick, MD, PhD; Manisha Koirala


06:00 PM – 08:30 PM  Binaytara Foundation Gala Dinner


 

DAY 3 - APRIL 27, 2025

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


7:00 AM – 8:30 AM  Abstract Session

**This is a non-CME activity**


08:30 AM – 09:15 AM  Session 13: The Role of Policy in Supporting Cancer Health Equity

Session Chair: Willie Underwood III, MD, MSc, MPH

08:30 AM – 08:45 AM  Keynote Speech

08:45 AM – 09:15 AM  Panel Discussion


09:15 AM – 10:00 AM  Session 14: Developing Effective Advocacy Campaigns

Session Chair: Dan Milner, MD, MSc, MBA

09:15 AM – 09:30 AM  Case 1

09:30 AM – 09:45 AM  Case 2

09:45 AM – 10:00 AM  Case 3


10:00 AM – 10:15 AM  Break & Exhibits


10:15 AM – 12:00 PM  Session 15: Debate - Crisis in Care: Can the U.S. Find a Sustainable Model for Affordable Healthcare?

Moderators: Anne-Marie Green

Panelists: Alan Balch, PhD


12:00 PM  Adjourn

Bell Harbor International Conference Center
2211 Alaskan Wy
Seattle, WA 98121
United States

Hotel Room Reservation

A limited number of guestrooms are reserved at the Seattle Marriott Waterfront for the participants of this meeting at a discounted rate of $247 per night. The room rate does not include any additional fees or applicable taxes.

CUTOFF - Thursday, March 27, 2025.

Parking 

Hotel offers daily valet parking at $58.

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Session Chair(s)

Catherine Duggan

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Yara Abdou, MD

has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Pfizer;.

Bradford Felker, MD

has no relevant financial relationships to disclose at this time.

Salene Jones, PhD, MA, LP

has no relevant financial relationships to disclose at this time.

Steven Kussick, MD, PhD

has a financial relationship (Professional Services) with Beckman Coulter Life Sciences;.
has a financial relationship (Employment) with Phenopath, A Quest Diagnostics Company;.

Memnun Seven, RN. MSN, PhD, FAAN

has no relevant financial relationships to disclose at this time.

Helen Storey, MS PhD

has no relevant financial relationships to disclose at this time.
Planning committee(s)

Don Dizon, MD, FACP, FASCO

has a financial relationship (Professional Services) with Puma;.
has a financial relationship (Professional Services) with Astra Zeneca;.
has a financial relationship (Professional Services) with Clovis;.
has a financial relationship (Professional Services) with GSK;.
has a financial relationship (Grant Or Contract) with BMS;.

Shipra Gandhi, MD, MS

has a financial relationship (Professional Services) with Aptitude Health;.
has a financial relationship (Professional Services) with MedPage Today;.
has a financial relationship (Professional Services) with OncLive;.
has a financial relationship (Other) with Novartis;.

Changchuan(Charles) Jiang, MD, MPH

has no relevant financial relationships to disclose at this time.

Manish Kohli

has a financial relationship (Travel) with Apollo Hospital Enterprise Limited;.
has a financial relationship (Travel) with Triomics;.
has a financial relationship (Professional Services) with Tempus Inc;.
has a financial relationship (Professional Services) with Janssen Scientific Affairs, LLC;.

Martha Mims

has a financial relationship (Stock) with Biogen IDEC;.
has a financial relationship (Stock) with Amgen;.

Arya Mariam Roy, MD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 17.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 17.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 17.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 17.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 17.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 17.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$350.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.